BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afghani E, Lo SK, Covington PS, Cash BD, Pandol SJ. Sphincter of Oddi Function and Risk Factors for Dysfunction. Front Nutr 2017;4:1. [PMID: 28194398 DOI: 10.3389/fnut.2017.00001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS. Safety of Eluxadoline in Patients With IBS-D Without a Gallbladder. Am J Gastroenterol 2017;112:1619-20. [PMID: 28978951 DOI: 10.1038/ajg.2017.257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 Menon S, Holt A, Farmer AD. Intra-sphincteric botulinum toxin in the management of functional biliary pain. Endosc Int Open 2022;10:E521-7. [DOI: 10.1055/a-1784-0061] [Reference Citation Analysis]
3 Del Vecchio Blanco G, Gesuale C, Varanese M, Monteleone G, Paoluzi OA. Idiopathic acute pancreatitis: a review on etiology and diagnostic work-up. Clin J Gastroenterol 2019;12:511-24. [DOI: 10.1007/s12328-019-00987-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Keating GM. Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome. Drugs 2017;77:1009-16. [DOI: 10.1007/s40265-017-0756-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS. Response to Lai. Am J Gastroenterol 2019;114:1177-8. [PMID: 31205133 DOI: 10.14309/ajg.0000000000000312] [Reference Citation Analysis]
6 Berger Z, S AMM. Paradoxical Stimulatory Response of Remanent Sphincter of Oddi to Buscapina After Endoscopic Sphincterotomy. J Neurogastroenterol Motil 2021;27:632-8. [PMID: 34642284 DOI: 10.5056/jnm20180] [Reference Citation Analysis]
7 Wang Y, Chang H, Zhang Y, Wang K, Zhang H, Yan X, Meng L, Yao W, Li K, Huang Y. Endoscopic endoclip papilloplasty preserves sphincter of oddi function. Eur J Clin Invest 2021;51:e13408. [PMID: 32929751 DOI: 10.1111/eci.13408] [Reference Citation Analysis]
8 Chen JM, Yan XY, Zhu T, Chen ZX, Zhao YJ, Xie K, Liu FB, Geng XP. T-tube drainage versus choledochojejunostomy in hepatolithiasis patients with sphincter of Oddi laxity: study protocol for a randomized controlled trial. Trials 2020;21:586. [PMID: 32600474 DOI: 10.1186/s13063-020-04483-z] [Reference Citation Analysis]
9 Ren LK, Cai ZY, Ran X, Yang NH, Li XZ, Liu H, Wu CW, Zeng WY, Han M. Evaluating the efficacy of endoscopic sphincterotomy on biliary-type sphincter of Oddi dysfunction: A retrospective clinical trial. World J Clin Cases 2021; 9(32): 9835-9846 [PMID: 34877322 DOI: 10.12998/wjcc.v9.i32.9835] [Reference Citation Analysis]
10 Andrews CN, Bradette M. Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update. J Can Assoc Gastroenterol 2020;3:e37-48. [PMID: 33241185 DOI: 10.1093/jcag/gwz034] [Reference Citation Analysis]
11 Chedid V, Vijayvargiya P, Camilleri M. Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clin Gastroenterol Hepatol 2018;16:336-8. [PMID: 29155353 DOI: 10.1016/j.cgh.2017.11.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Alkarrash MS, Shashaa MN, Rhayim R, Aljarad Z. Misdiagnosis of sphincter of Oddi disorder treated as familial Mediterranean fever for ten years: A case report. Annals of Medicine and Surgery 2022;74:103295. [DOI: 10.1016/j.amsu.2022.103295] [Reference Citation Analysis]
13 Ungur M, Babes PA, Maghiar A, Pop GM, Feder B. Diagnosis and Therapeutic Management in Postcholecistectomy Alithiasic Cholangitis. Maedica (Bucur) 2019;14:247-53. [PMID: 31798740 DOI: 10.26574/maedica.2019.14.3.247] [Reference Citation Analysis]
14 Liu R, Staller K. Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Drug Des Devel Ther 2020;14:1391-400. [PMID: 32308371 DOI: 10.2147/DDDT.S216056] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 González I, Roper S. Elevated Lipase in an Infant with Altered Mental Status. Lab Med 2020;51:e38-41. [PMID: 31833546 DOI: 10.1093/labmed/lmz090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Levio S, Cash BD. The place of eluxadoline in the management of irritable bowel syndrome with diarrhea. Therap Adv Gastroenterol 2017;10:715-25. [PMID: 28932272 DOI: 10.1177/1756283X17721152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
17 Zhou B, Hu J, Zhong Y. Surgical treatments for patients with recurrent bile duct stones and Oddis sphincter laxity. Intractable Rare Dis Res 2017;6:172-6. [PMID: 28944138 DOI: 10.5582/irdr.2017.01053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Garcia-Gonzalez F, Faghih M, Singh V. Letter: eluxadoline-associated acute pancreatitis-myth or reality? Aliment Pharmacol Ther 2018;48:490-1. [PMID: 30588698 DOI: 10.1111/apt.14846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Bálint ER, Fűr G, Kui B, Balla Z, Kormányos ES, Orján EM, Tóth B, Horváth G, Szűcs E, Benyhe S, Ducza E, Pallagi P, Maléth J, Venglovecz V, Hegyi P, Kiss L, Rakonczay Z Jr. Fentanyl but Not Morphine or Buprenorphine Improves the Severity of Necrotizing Acute Pancreatitis in Rats. Int J Mol Sci 2022;23:1192. [PMID: 35163111 DOI: 10.3390/ijms23031192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Al-Khoury N, Mohamad O, Mazloum AA, Madi M. Biliary type-II sphincter of Oddi dysfunction with a pancreatic duct dilation: a case report and review of the literature. J Med Case Rep 2021;15:82. [PMID: 33612115 DOI: 10.1186/s13256-021-02674-z] [Reference Citation Analysis]
21 Cash BD, Lacy BE, Watton C, Schoenfeld PS, Weissman D. Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change. Therap Adv Gastroenterol 2021;14:17562848211001725. [PMID: 33953798 DOI: 10.1177/17562848211001725] [Reference Citation Analysis]
22 Kudo M, Kobayashi S, Kojima M, Kobayashi T, Sugimoto M, Takahashi S, Konishi M, Ishii G, Gotohda N. Impact of previous history of choledochojejunostomy on the incidence of organ/space surgical site infection after hepatectomy. Asian J Surg 2021:S1015-9584(21)00178-0. [PMID: 33863626 DOI: 10.1016/j.asjsur.2021.03.029] [Reference Citation Analysis]